<DOC>
	<DOCNO>NCT02387944</DOCNO>
	<brief_summary>The purpose study assess coagulation platelet function child congenital heart disease , measure bedside device ( thromboelastometry impedance aggregometry ) . The investigator also aim determine device detect post-cardiopulmonary bypass clot derangement may help manage bleed population .</brief_summary>
	<brief_title>Bedside Evaluation Coagulation Children With Congenital Heart Disease</brief_title>
	<detailed_description>Hemostasis , main concern surgical procedure , traditionally monitor follow laboratory test : activate Partial Thrombin Time ( aPTT ) , prothrombin time ( PT ) , fibrinogen , platelet count . They neither provide reliable estimate risk bleeding , allow determine useful intervention . New investigation hemostasis use validate surgery : Rotational Thromboelastometry ( ROTEM速 ) impedance aggregometry . This quick bedside functional analysis patient 's clotting . Children undergo surgery cardiopulmonary bypass ( CPB ) particularly risk bleed population n't study large cohort yet . Hypothesis : Hemostasis child CHD , especially cyanotic , intrinsically abnormal . The corrective surgery CPB induce hemostatic disorder identify ROTEM platelet速 . The aim study evaluate hemostatic function child congenital heart disease use Point-Of-Care ( platelet-ROTEM 速 ) system , surgery alteration induce cardiopulmonary bypass ( CPB ) . This single center , observational , prospective study . Expected duration : 2 year . The investigator plan include 200 patient CHD , 100 patient undergoing surgery CPB 100 patient congenital heart disease require cardiac catheterization . Recruitment conduct Division Paediatric Cardiology . Inclusion criterion include age 0-16 year diagnosis congenital heart disease require surgery CPB cardiac catheterization . Patients know dyscrasia treat antiaggregant within 10 days/oral anticoagulant within 48h surgery/catheterization . ROTEM platelet速 test perform surgery/catheterization . Patients undergo surgery second test within 30 minute end cardiopulmonary bypass . All patient benefit usual care .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>child 0 16 year , bear congenital heart disease require either cardiac catheterization surgery cardiopulmonary bypass parental and/or patient consent know hemostatic disorder know platelet function disorder antiaggregation treatment &lt; 10 day blood sample oral anticoagulation &lt; 2 day blood sample intravenous heparin &lt; 6 hour blood sample patient parent unable consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Children</keyword>
	<keyword>Cyanotic congenital heart defect</keyword>
	<keyword>Cardiopulmonary Bypass</keyword>
	<keyword>Thromboelastometry</keyword>
	<keyword>Platelet Function Tests</keyword>
</DOC>